CClinicalTrials.gg
WithdrawnNCT04755686Updated Feb 16, 2021

Effects of Fast-tracking Geriatric Hip Fracture Patients

An interventional study of Fast-tracking in Hip Fracture, sponsored by Sahlgrenska University Hospital. Withdrawn at 1 site in Sweden. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2021-02-16.

Sponsored by Sahlgrenska University Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether fast-tracking hip fracture patients to geriatric medicine wards, as opposed to standard care at the emergency room, results in less complications and shorter hospitalization for the patients.

Read the detailed description

Each year about 18000 persons in Sweden suffer from a hip fracture. These people are often among the oldest and have many complicating diseases. The one-year mortality after hip fracture is 20%. Due to the complexity including many comorbidities in these patients, it is of great value that the care of these patients is optimal.

Today, most of the patients with suspected hip fracture in the catchment area of Sahlgrenska University hospital, Gothenburg, are transported directly to the radiology unit. Thereafter, the patient waits in the emergency room (ER) for an othopedic examination before being admitted to primarily a geriatric medicine ward where they wait for the operation. The average waiting time in the ER is today around four hours. The current scientific evidence for fast-tracking hipfracture patients is limited. The aim of our randomized controlled trial is to determine the effect of fast-tracking hip fracture patients at geraitric medicine wards compared to standard care regarding complication rate (primary endpoint), lenght of hospital stay and time to operation (secondary outcomes).

02

Conditions studied

  • Hip Fracture

Keywords

  • hip fracture
  • fast-tracking
  • complications
03

In context

Fractures, Bone

2,261 studies on the registry are indexed under Fractures, Bone; 325 are open to participants now.

Browse Fractures, Bone studies →

Lead sponsor

Sahlgrenska University Hospital is the lead sponsor of 259 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients with low energy trauma with pain at the hip and/or groin AND
  • respiratory frequency: 8-25/minute AND
  • saturation: 90% or higher on air AND
  • pulse: 50-119 beats per minute AND
  • systolic blood pressure: >90 mmHg AND
  • level of consciousness: Reaction level scale (RLS) 1 or Glasgow Coma Scale (GCS) 14-15 AND
  • plasma-glucose: 3,0-25 mmol/l

Exclusion criteria

Exclusion Criteria:

We will exclude patients based on the following criteria:

  • distal status affected
  • suspicion of other simultaneous fracture
  • suspicion of head trauma or affected consciousness
  • suspicion of acute cardiac disease
  • signs of acute cardiac ischemia in electrocardiogram
  • generalized symtoms, except for pain in the hip
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Fast-tracking at geriatric medicine ward

    Fast-tracking hip fracture patients at geriatric medicine ward. The goal is to optimize the medical care of older hip fracture patients at a geriatric ward and to shorten the time to operation.

    Procedure: Fast-tracking

  • No intervention
    Regular admission

    Regular admission and care of hip fracture patients at the emergency room prior to surgery.

Interventions

  • ProcedureFast-tracking
06

What researchers measure

Primary outcomes

  1. Incidence of complications (composit endpoint of non-fatal major bleeding, pressure ulcer, non-fatal infections, confusion, non-fatal tromboembolic events, all-cause mortality)

    Time frame: at time of discharge from geriatric medicine ward, after four months and after one year

Secondary outcomes

  1. Length of hospital stay, time to operation, all-cause mortality, functional ability after discharge, proportion of patients returning to former living, self assessed health status

    Time frame: At time of discharge from geriatric medicine ward, after four months and after one year

07

Study locations

1 site
  • Sahlgrenska University Hospital, Mölndal
    Gothenburg, Sweden
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04755686
Lead sponsor
Sahlgrenska University Hospital
Responsible party
Mattias Lorentzon (Associate Professor, MD, PhD, Sahlgrenska University Hospital) — Principal investigator
First posted
Feb 16, 2021
Start date
Jun 2013
Primary completion
Jun 2016 (estimated)
Completion
Jun 2017 (estimated)
Last update
Feb 16, 2021

Study contacts

Mattias Lorentzon, MD, PhD
principal investigator · Geriatric Medicine, Sahlgrenska University Hospital, Mölndal

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion